Mesoblast Ltd has released a press release.
Voluntary Suspension
Filed with ASX ·
Watch Mesoblast's latest callMesoblast (ASX:MSB) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Mesoblast (ASX:MSB) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Earlier from Mesoblast
- FDA Accepts Mesoblasts BLA Resubmission for Remestemcel-L
- DREAM HF Trial Published in JACC
- Half Yearly Report and Accounts
- Mesoblast Completes Resubmission of BLA to FDA for SR-aGVHD
- Extension of Undrawn US$30 million Facility
Later from Mesoblast
- Mesoblast Completes Private Placement
- Reinstatement to Official Quotation
- Third Quarter Financial Results on Form 6-K
- MSB Reports Q3 Financial Results and Operational Highlights
- Update on BLA for Graft Versus Host Disease
Follow Mesoblast into a list and get an email when it puts out news.
Follow Mesoblast